Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
Article in Cancer Cell (May 2022)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Cancer Cell (May 2022)
Article in Blood (April 2022)
Article in The Oncologist (March 2022)